Steve specialises in biotechnology inventions, with particular expertise in therapeutic/diagnostic antibodies and disease biomarkers. He has extensive experience of patent prosecution at the European Patent Office, including oppositions and appeals, and has also supported national patent litigation in the UK and Scandinavia.
MA (Oxon) in biochemistry, DPhil (Neuroscience), Chartered Patent Attorney, European Patent Attorney.
Research/industry experience: DPhil (Neuroscience) at the University of Oxford, 1991-1994, Post-doctoral research scientist at the University of Oxford, 1995-1998
Steve read biochemistry at the University of Oxford before undertaking a doctorate degree in neuroscience. After completing his doctorate, Steve remained in Oxford and spent three years as a post-doctoral scientist, authoring a number of scientific papers.
Steve joined Potter Clarkson in 1998 and became a partner in 2007.
Steve acts for a range of clients including multinational companies, early-stage and established biotech companies based throughout Europe, as well as government-funded research institutes and universities.
He has lectured and written numerous articles on the patenting of biotechnological inventions.
Examples of clients:
- GlaxoSmithKline (GSK)
- Novo Nordisk
- Alligator Bioscience
- Destiny Pharma
Steve has extensive experience of patent prosecution at the European Patent Office, including oppositions and appeals, and has also been actively involved in supporting national patent litigation in the UK and Scandinavia.
Clients praise Steve for his broad scientific knowledge, keen advocacy skills and pragmatic commercial advice.